Clinical Parameters of the International Index and Chromosomal Abnormalities as Risk Factors for Survival in 68 Patients With cb and 28 Patients With B-ib Lymphoma (Multivariate Analyses)
| . | cb Lymphomas . | ib Lymphomas . | ||
|---|---|---|---|---|
| P Value . | Risk Ratio . | P Value . | Risk Ratio . | |
| Clinical Risk Factor | ||||
| Age >60 yr | .37 | 1.47 | 0.81 | 1.14 |
| Clinical Stage (Ann Arbor Stage III or IV) | .61 | 0.80 | 0.76 | 0.83 |
| Serum LDH >240 U/l | .19 | 1.79 | 0.36 | 1.88 |
| Karnofsky Index ≤70% | .01 | 0.25 | 0.03 | 0.12 |
| No. of E-sites4-150 ≥2 | .32 | 0.53 | 0.60 | 0.65 |
| Clinical Risk Factor or Chromosomal Abnormality | ||||
| Age >60 yr | .018 | 1.05 | — | — |
| Clinical Stage (Ann Arbor Stage III or IV) | .035 | 2.44 | — | — |
| dup(1)(q) | .065 | 2.27 | — | — |
| del(1)(q) | .084 | 2.39 | — | — |
| +5 | .089 | 0.17 | — | — |
| der(15)(q) | .125 | 0.19 | — | — |
| Karnofsky Index ≥70% | — | — | .001 | 0.01 |
| der(8)(q) | — | — | .003 | 13.20 |
| der(7)(q) | — | — | .009 | 6.91 |
| . | cb Lymphomas . | ib Lymphomas . | ||
|---|---|---|---|---|
| P Value . | Risk Ratio . | P Value . | Risk Ratio . | |
| Clinical Risk Factor | ||||
| Age >60 yr | .37 | 1.47 | 0.81 | 1.14 |
| Clinical Stage (Ann Arbor Stage III or IV) | .61 | 0.80 | 0.76 | 0.83 |
| Serum LDH >240 U/l | .19 | 1.79 | 0.36 | 1.88 |
| Karnofsky Index ≤70% | .01 | 0.25 | 0.03 | 0.12 |
| No. of E-sites4-150 ≥2 | .32 | 0.53 | 0.60 | 0.65 |
| Clinical Risk Factor or Chromosomal Abnormality | ||||
| Age >60 yr | .018 | 1.05 | — | — |
| Clinical Stage (Ann Arbor Stage III or IV) | .035 | 2.44 | — | — |
| dup(1)(q) | .065 | 2.27 | — | — |
| del(1)(q) | .084 | 2.39 | — | — |
| +5 | .089 | 0.17 | — | — |
| der(15)(q) | .125 | 0.19 | — | — |
| Karnofsky Index ≥70% | — | — | .001 | 0.01 |
| der(8)(q) | — | — | .003 | 13.20 |
| der(7)(q) | — | — | .009 | 6.91 |
E-sites, extranodal manifestation.